A role for SSU72 in balancing RNA polymerase II transcription elongation and termination by Dichtl, Bernhard et al.
          Deakin Research Online 
 
This is the published version:  
 
Dichtl, Bernhard, Blank, Diana, Ohnacker, Martin, Friedlein, Arno, Roeder, Daniel, Langen, 
Hanno and Keller, Walter 2002, A role for SSU72 in balancing RNA polymerase II 
transcription elongation and termination, Molecular cell, vol. 10, no. 5, pp. 1139-1150. 
 




Reproduced with the kind permission of the copyright owner 
  
Copyright : 2002, Elsevier (Green Journal) 
Molecular Cell, Vol. 10, 1139–1150, November, 2002, Copyright 2002 by Cell Press
A Role for SSU72 in Balancing RNA Polymerase II
Transcription Elongation and Termination
The C-terminal domain (CTD) of the largest subunit
of RNAP II links transcription and 3 end processing
(reviewed in Bentley, 2002; Proudfoot et al., 2002). The
Bernhard Dichtl,1,3 Diana Blank,1 Martin Ohnacker,1
Arno Friedlein,2 Daniel Roeder,2 Hanno Langen,2
and Walter Keller1,3
mammalian CTD promotes 3 end cleavage in vivo1Department of Cell Biology
(McCracken et al., 1997) and in vitro (Hirose and Manley,Biozentrum
1998; Ryan et al., 2002); the yeast CTD has not beenUniversity of Basel
implicated directly in 3 end processing, but transcrip-Klingelbergstrasse 70
tion in the absence of the CTD in vivo reduced cleavageCH-4056 Basel
and poly(A) tail length (Licatalosi et al., 2002; McNeil2 Roche Genetics
et al., 1998). Site-specific phosphorylation of the CTDF. Hoffmann-La Roche Ltd.
controls the association of pre-mRNA processing fac-Grenzacherstrasse 124
tors (Cho et al., 2001; Komarnitsky et al., 2000; LicatalosiCH-4070 Basel
et al., 2002). Interactions with the CTD were reportedSwitzerland
for yeast CF IA (Barilla et al., 2001; Licatalosi et al., 2002)
and CPF (Dichtl et al., 2002; Rodriguez et al., 2000) and
mammalian CPSF and CstF (Fong and Bentley, 2001;Summary
McCracken et al., 1997). Recruitment of 3 end factors
to RNAP II requires the CTD and occurs progressivelyInteractions of pre-mRNA 3end factors and the CTD
during transcription (Licatalosi et al., 2002). How suchof RNA polymerase II (RNAP II) are required for tran-
recruitment is promoted in yeast is unclear. In mammals,scription termination and 3end processing. Here, we
the general transcription factor TFIID was suggested todemonstrate that Ssu72p is stably associated with
act in the transfer of CPSF to RNAP II (Dantonel et al.,yeast cleavage and polyadenylation factor CPF and
1997).provide evidence that it bridges the CPF subunits
The requirement for functional poly(A) signals in termi-Pta1p and Ydh1p/Cft2p, the general transcription fac-
nation indicated a role of 3 end factors in transcriptiontor TFIIB, and RNAP II via Rpb2p. Analyses of ssu72-2
(reviewed in Proudfoot, 1989). Poly(A) signal transduc-mutant cells in the absence and presence of the nu-
tion to RNAP II was proposed to be mediated by twoclear exosome component Rrp6p revealed defects in
alternative, but not mutually exclusive, mechanisms (re-RNAP II transcription elongation and termination.
viewed in Proudfoot et al., 2002). The antiterminator6-azauracil, that reduces transcription elongation
model proposed that 3 end factors transform RNAP IIrates, suppressed the ssu72-2 growth defect at 33C.
into a termination-competent state upon poly(A) siteThe sum of our analyses suggests a negative influence
recognition. The “torpedo” model necessitated 3 endof Ssu72p on RNAP II during transcription that affects
cleavage and subsequent exonucleolytic degradation ofthe commitment to either elongation or termination.
the downstream cleavage product that would eventually
interfere with RNAP II. The Rna15p, Rna14p, and Pcf11pIntroduction
subunits of CF IA (Barilla et al., 2001; Birse et al., 1998)
and the CPF subunit Yhh1p/Cft1p (Dichtl et al., 2002)Most pre-mRNA templates for the expression of protein
were shown to be required for termination. Rna15p ter-coding genes in eukaryotes are produced by RNAP II
mination activity is antagonized by Sub1p (Calvo andand matured by 5 capping, splicing, and 3 poly(A) addi-
Manley, 2001) and possibly integrated with cell cycle
tion. 3 end formation involves pre-mRNA cleavage fol-
events (Aranda and Proudfoot, 2001). snoRNA transcrip-
lowed by polyadenylation of the upstream cleavage
tion termination requires the Nrd1p complex (Steinmetz
product. In yeast cleavage factors I and II (CF I and CF et al., 2001).
II), polyadenylation factor I (PF I) and poly(A) polymerase Ssu72p is an essential protein of 206 amino acids (Sun
were defined as sufficient for 3 end processing (Chen and Hampsey, 1996). The ssu72-1 mutation conferred
and Moore, 1992). CF I was further separated into CF temperature sensitivity (ts) and strongly enhanced the
IA and CF IB (Kessler et al., 1996); CF II and PF I form defect of a mutation in TFIIB (sua7-1) in transcriptional
the cleavage and polyadenylation factor CPF (Ohnacker start site selection; however, growth and biochemical
et al., 2000). The polypeptide composition of 3 end phenotypes of ssu72-1 were dependent on sua7-1 (Sun
factors is complex, and many of the components were and Hampsey, 1996). Interestingly, mutants in SSU72
functionally analyzed (Zhao et al., 1999). The majority and SUB1 enhanced defects in start site selection in an
of yeast 3 end factors have recognizable metazoan overlapping set of mutant TFIIB genes (Wu et al., 1999).
counterparts (reviewed in Shatkin and Manley, 2000); The ssu72-2 allele conferred a ts phenotype indepen-
CF IA and CPF contain homologs of mammalian CstF dent of sua7-1. Defects of this mutation in noninduced
and CPSF factors, respectively. Interestingly, snoRNA gene expression in combination with physical interac-
production requires 3 end cleavage uncoupled from tions with RNAP II and TFIIB suggested an important
polyadenylation (Fatica, et al., 2000). function for Ssu72p in transcription (Pappas and Hamp-
sey, 2000; Wu et al., 1999).
In this work we demonstrate that Ssu72p is an integral3 Correspondence: walter.keller@unibas.ch (W.K.), bernhard.dichtl@
unibas.ch (B.D.) component of CPF. Our functional analyses suggest that
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Figure 1. Ssu72p Is Stably Associated with CPF
(A) CPF obtained after IgG-agarose purification of ProtA-Pfs2p from extracts was applied to a SMART MiniQ column. 0.25 of 50 l fractions
obtained after elution with a linear KCl gradient was separated by SDS-PAGE on a 10% gel and analyzed by silver staining. The numbers of
the analyzed fractions, the KCl gradient, and migration of molecular weight markers in kilodaltons are indicated.
(B) Cleavage activity profile of MiniQ fractions. One microliter of a 1/100 dilution of fractions numbered as in (A) was incubated with 1 l
purified CF IA, 10 ng GST-Nab4p, and synthetic CYC1 pre-mRNA (lanes 5–15). Buffer was added in lane 4 and extract replaced factors in
lane 3. Lane 2 shows the RNA input. The positions of CYC1 substrate, 5 and 3 cleavage products, and HpaII-digested pBR322 marker bands
(M; lane 1) are indicated.
(C) Polypeptides present in MiniQ peak fractions were identified by MALDI-TOF-MS or nanoelectrospray tandem mass spectrometry. Protein
names according to the Saccharomyces Genome Database (http://genome-www.stanford.edu/saccharomyces) and molecular weight stan-
dards in kilodaltons are indicated. The asterisk indicates an unidentified band that gave no peptide fragments following digestion with trypsin
or Glu-C proteases.
(D) Western analysis of eluates obtained by IgG-agarose purification of extracts from the indicated strains. The analyzed subunits of CPF and
CF IA are indicated.
(E) Analysis of in vitro cleavage and polyadenylation activity associated with TEV eluates derived from ProtA-Ssu72p and ProtA-Pfs2p extracts
with a synthetic CYC1 pre-mRNA. In vitro cleavage was assayed with 3 l eluate obtained from strains expressing proteinA fusions as indicated
in the absence (lanes 3 and 4) and the presence (lanes 5–8) of 1 l CF IA. Reactions in lanes 6 and 8 were also complemented with 100 ng
GST-Nab4p (CF IB). Substrate was incubated with buffer (lane 1) or CF IA only (lane 2). Coupled cleavage and polyadenylation was assayed
with 3 l TEV eluate in the absence of other factors (lanes 11 and 12) or in the presence of 1 l CF IA, 100 ng GST-Nab4p, and 80 ng Pab1p
(lanes 13 and 14). For control, substrate was incubated with buffer (lane 9) or CF IA only (lane 10). Migration of substrate (CYC1), specific (5
and 3) and cryptic (asterisks) cleavage products, specific and nonspecific polyadenylation products and marker bands is indicated.
Ssu72p is required for antitermination activity of CPF a protein A-tagged version of the Pfs2p subunit (see
Experimental Procedures). Further purification by SMARTduring RNAP II elongation, and that reversal of this func-
tion during poly(A) site recognition contributes to termi- MiniQ chromatography resulted in coelution of at least
15 polypeptides (Figure 1A). The MiniQ fractions werenation.
tested for in vitro cleavage in the presence of CF IA and
CF IB (GST-Nab4p). Activity peaked in fraction 32 (FigureResults
1B), whereas the peak in the protein elution profile was
at fraction 33 (Figure 1A). The reason for this slight shiftMass Spectrometric Analysis of Polypeptides
Associated with CPF is currently unclear.
Polypeptides in MiniQ peak fractions were sequencedTo identify polypeptides associated with CPF, we puri-
fied the factor on IgG-agarose from yeasts that express by peptide fingerprinting with MALDI-MS analysis and
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nanoelectrospray tandem mass spectrometry (summa- Ssu72p Bridges CPF, TFIIB, and the Rpb2p
Subunit of RNAP IIrized in Figure 1C). We identified the known CPF sub-
To investigate interactions mediated by Ssu72p, we per-units (Ohnacker et al., 2000) Ydh1/Cft2p, Pta1p, Ysh1p/
formed pull-down experiments with GST-Ssu72p andBrr5p, Pap1p, Mpe1p (Vo et al., 2001), Pfs2p, and Fip1p.
16 individually in vitro-translated 3 end factor subunits.Yhh1p/Cft1p was verified by Western blot (data not
Figure 2A shows a representative experiment in whichshown). A systematic proteomic approach proposed the
GST-Ssu72p strongly interacted with Pta1p (lane 17)association of novel proteins with the 3 end processing
and weaker with Ydh1p/Cft2p (lane16). No interactionsmachinery (Gavin et al., 2002). We found five of those
could be detected with other CPF subunits (Yhh1p/proteins (Ref2p, Pti1p, Swd2p/Saf37p/Cps35p, Glc7p,
Cft1p, Ysh1p/Brr5p, Pfs2p, Mpe1p, Pap1p, Fip1p,and Ssu72p) in the CPF fractions. Ref2p was previously
Yth1p, and p20p), CF IA subunits (Rna15p, Rna14p,implicated in 3 end cleavage (Russnak et al., 1995).
Pcf11p, and Clp1p), CF IB (Nab4p/Hrp1p), and Pab1pPti1p was isolated as yeast two-hybrid interactor with
(Figure 2A and data not shown). Consistent with thePTA1, but its function remains unknown (W. Hu¨bner and
reported interaction of in vitro-translated Ssu72p andW.K., unpublished data). Interestingly, Swd2p/Saf37p/
recombinant TFIIB (Sua7p) (Wu et al., 1999), we ob-Cps35p was also found associated with the SET1C com-
served binding of in vitro-translated Sua7p to GST-plex that functions in the methylation of histone 3 lysine
Ssu72p (Figure 2B, lane 7). In vitro-translated Ssu72p4 (Miller et al., 2001; Nagy et al., 2002; Roguev et al.,
was furthermore reported to interact with purified RNAP2001). This protein might therefore serve a dual function
II (Pappas and Hampsey, 2000). Since a point mutationas component of CPF and SET1C. The catalytic subunit
in the Rpb2p subunit of RNAP II (rpb2-100) suppressedof protein phosphatase 1, Glc7p, has a wide range of
the ssu72-2 ts growth defect (Pappas and Hampsey,cellular substrates, but its role as component of CPF is
2000), we tested for interaction of these proteins. Rpb2punclear (Walsh et al., 2002). Ssu72p was implicated in
is a 135 kDa protein and in vitro translation generatedtranscription (Sun and Hampsey, 1996). A novel 20 kDa
a 95 kDa product that may originate from prematureprotein encoded by a nonessential gene (YDL094c) is
translational termination. This protein interacted withindicated as p20. Repeated attempts to identify the 65
GST-Ssu72p, but not with GST alone (Figure 2B, laneskDa band (indicated by an asterisk) were not successful.
8 and 15). All observed interactions also occurred when
RNase A and DNase I were included in the binding reac-
tion, excluding that interactions were mediated by nu-Ssu72p Is Stably Associated with CPF
cleic acid (data not shown). Next, we tested how mutantThe presence of Ssu72p in CPF suggested a link be-
GST-ssu72-2p behaved that has a single amino acidtween 3 end formation and transcription that we investi-
change (R129A). GST-ssu72-2p bound Ydh1p/Cft2p,gated in detail. Reverse tagging of Ssu72p with a
Pta1p, Sua7p, and Rpb2p (Figure 2B, lanes 9–12) repro-C-terminal tandem affinity tag did not confirm the stable
ducibly with a slightly lower efficiency compared to wild-association with 3 end factors (Gavin et al., 2002). We
type GST-Ssu72p (lanes 5–8).tested this with a strain that expressed Ssu72p with a
To corroborate these results we used the GAL4-basedN-terminal protein A tag; this strain displayed slow
two-hybrid system. Plasmids carrying the GAL4 DNAgrowth at 15C (data not shown). Extracts from ProtA-
binding domain fused to SSU72 (pBD-SSU72) or mutantSSU72 and ProtA-PFS2 strains and from a strain ex-
ssu72-2 (pBD-ssu72-2), and plasmids carrying the GAL4pressing a protein A-tagged version of the CF IA subunit
activation domain fused to test genes (pACT-YDH1,Rna15p were purified on IgG-agarose. Western analyses
pACT-PTA1, pACT-SUA7, and pACT-RPB2) were co-revealed that ProtA-Ssu72p and ProtA-Pfs2p eluates
transformed in strain Y190. Positive two-hybrid interac-contained CPF subunits (Figure 1D, lanes 1 and 2;
tions activate transcription of a HIS3 reporter gene andYsh1p/Brr5p, Pfs2p, Fip1p, and Pap1p) but not CF IA
allow growth on medium lacking histidine. pBD-SSU72
subunits (Rna14p, Rna15p, or Pcf11p). In contrast, CF IA
and pBD-ssu72-2 did not promote growth in the pres-
but no CPF subunits were present in the ProtA-Rna15p
ence of empty pACT (Figure 2C). No His phenotype
eluate (lane 3). was observed when pACT-SUA7 (TFIIB) was tested in
ProtA-Ssu72p and ProtA-Pfs2p eluates were inactive the presence of either wild-type or mutant SSU72 (data
for cleavage of synthetic CYC1 pre-mRNA (Figure 1E, not shown). pACT-PTA1 gave a His growth phenotype
lanes 3 and 4). Addition of CF IA gave 5 and 3 cleavage under stringent conditions (35 mM 3-amino-1,2,4-tri-
products together with cryptic cleavage products (lanes azole; 3-AT) with pBD-SSU72 that was strongly reduced
5 and 7). Cryptic cleavage occurred due to the absence with pBD-ssu72-2. pACT-YDH1 and pACT-RPB2 gave
of CF IB (Minvielle-Sebastia et al., 1998) and was sup- a His phenotype under moderate stringency (17.5 mM
pressed by addition of CF IB (GST-Nab4p; lanes 6 and 3-AT) that was reduced with pBD-ssu72-2. Figure 2D
8). In a coupled cleavage and polyadenylation assay, shows that BD-Ssu72p and BD-ssu72-2p proteins were
ProtA-Ssu72p and ProtA-Pfs2p eluates displayed non- expressed at comparable levels. Furthermore, levels of
specific polyadenylation activity in the absence of other endogenous mutant ssu72-2p remained stable at 37C;
factors, that is characteristic for CPF (lanes 11 and 12) equal amounts of Rna15p served as loading control.
(Ohnacker et al., 2000). In the presence of CF IA, CF IB, Taken together, we found that Ssu72p interacted
and Pab1p both eluates were active in specific polyade- strongly with Pta1p and weaker with Ydh1p/Cft2p and
nylation of the upstream cleavage product that origi- Rpb2p. The interaction with TFIIB observed in vitro
nated from cleavage of the pre-mRNA (lanes 13 and 14). could not be demonstrated by two-hybrid analysis. Fur-
In summary, the results shown in Figure 1 demonstrated thermore, interactions were impaired with mutant
ssu72-2p.that Ssu72p is stably associated with CPF.
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Figure 2. Ssu72p Bridges CPF, TFIIB, and the Rpb2p Subunit of RNAP II
(A) Pull-down experiments with 1 g GST-Ssu72p (lanes 10–18) and indicated [35S]-methionine-labeled proteins. Input (lanes 1–9) shows 10%
of in vitro translation reactions included in binding reactions. Migration of 14C-labeled molecular weight standards (M) is indicated in kilodaltons.
The band visible in the Pfs2p lane (lane 12) does not correspond to full-length protein and was also observed with GST alone (data not shown).
(B) Pull-down experiments as described in (A) with 1 g GST (lanes 13–15), 1 g GST-Ssu72p (lanes 5–8), or 1 g GST-ssu72-2p (lanes 9–12)
and in vitro-translated proteins as indicated.
(C) Plasmids carrying SSU72 (pBD-SSU72) or ssu72-2 (pBD-ssu72-2) fused to the GAL4 DNA binding domain and plasmids carrying test
genes fused to the GAL4 activation domain (pACT-YDH1, pACT-PTA1, and pACT-RPB2) were cotransformed into strain Y190. Ten-fold serial
dilutions of the resulting strains were spotted on medium lacking leucin (Leu), tryptophan (Trp), and histidine (His), as indicated. Activation
of HIS3 expression was tested in the presence of the indicated amounts of 3-amino-1,2,4-triazole (3-AT) at 30C. For control, pBD-SSU72
and pBD-ssu72-2 vectors were tested in the presence of empty pACT-vector.
(D) Protein lysates were produced from wild-type, ssu72-2, and two-hybrid strains (carrying pBD-SSU72 or pBD-ssu72-2 plasmids) grown at
the indicated temperatures (4 hr for 37C samples), and Western analysis was done with Ssu72p- and Rna15p-specific antisera. Positions of
Gal4p binding domain fusions with Ssu72p (BD-Ssu72p) and of endogenous Ssu72p and Rna15p are indicated. Asterisks mark Ssu72p proteins
that may result from degradation of pBD-Ssu72p.
Gene-Specific Defects of RNA Synthesis accumulate as stable RNAs, loss of RNAP II transcription
would be predicted to result in underaccumulation duein ssu72-2 Cells
An ssu72-2 strain was generated which was ts lethal; to dilution during continuing cell division. Notably, levels
of the U24 host mRNA ASC1 were strongly reduced inssu72-2 cells doubled at least twice before ceasing
growth after 6 hr at 37C (Figure 3D). To correlate the ssu72-2 mutant. We observed two forms of snR13
snoRNA. In addition to the mature 124 nt speciesssu72-2 lethality with in vivo phenotypes, we analyzed
steady-state RNAs extracted from wild-type and mutant (snR13m), a shorter RNA (snR13s) increased in abun-
dance in ssu72-2 cells with increasing time at 37C (Fig-cells before and after shift to 37C by Northern analyses
(Figure 3A). Levels of RNAP I-transcribed 18S rRNA and ure 3B, lanes 5 and 6). Primer extension analysis re-
vealed that snR13s resulted from an altered 5 endRNAP III-transcribed 5S rRNA remained stable at 37C.
Quantification of the tested mRNAs and normalization (Figure 3C). In addition to the primer extension product
corresponding to the 5 end of snR13, an16 nt shorterrelative to rRNA levels revealed reductions to the follow-
ing levels after 6 hr at 37C: 68% for PGK1, 64% for product accumulated in ssu72-2 cells (lanes 4–6). snR13s
might result from altered start site usage. However, allCYH2, 56% for CYC1, 48% for ACT1, and 40% for ADH1.
Levels of U14 snoRNA that are transcribed by RNAP known mutants that affect start site selection shift from
usage of the correct site to minor sites that also occurII in tandem with snoR190 and of intron-encoded U24
snoRNA remained constant, indicating that synthesis in the wild-type (Hampsey, 1998). Since we could not
detect snR13S in wild-type, posttranscriptional trimmingof these RNAs was unaffected. Although U14 and U24
SSU72 in Transcription Elongation and Termination
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Figure 3. Gene-Specific Defects of RNA Synthesis in ssu72-2 Cells
(A) Northern analyses of 10 g total RNA extracted from wild-type and ssu72-2 cells grown in YPD medium at 25C (lanes 1 and 3) or following
shift to 37C for 2, 4, and 6 hr (lanes 2 and 4–6). RNAs were resolved on formaldehyde/1.2% agarose gels or 8.3 M urea/8% polyacrylamide
gels. Filters were probed with random-primed labeled probes or end-labeled oligonucleotides directed against the indicated RNAs.
(B) Northern analysis as described in (A) with the snR13-3 oligonucleotide. Positions of mature snR13 (snR13m) and the short snR13 RNA
(snR13s) and of molecular weight markers are indicated.
(C) Primer extension analysis of the same total RNAs that were analyzed in (B) with the snR13-3 oligonucleotide. Primer extension products
were resolved on an 8.3 M urea/6% polyacrylamide gel. Products corresponding to the 5 end of the mature and the short form of snR13 and
molecular size markers are indicated.
(D) Wild-type and ssu72-2 strains were grown at 25C in YPD medium and transferred to a water-bath at 37C, and the OD600nm was monitored.
Cultures were continuously diluted with prewarmed medium to ensure exponential growth.
(E) Coupled cleavage and polyadenylation assays were carried out with 30–40 g total protein of extracts prepared from indicated strains
(lanes 2–5). Buffer (lane 1) indicates a mock-treated reaction. Positions of substrate RNA (CYC1), 5 cleavage (5) and polyadenylation products
(poly[A]), and of marker bands (M) are indicated.
of mature snR13 might produce snR13s for reasons un- Rrp6p. Rrp6p is a 3-5 exonuclease that was implicated
in the turnover of nonpolyadenylated and aberrantly ter-known (lanes 2 and 3). Interestingly, 5-truncated snR13
RNAs also accumulated in mutants of the putative RNA minated transcripts (Hilleren et al., 2001; Torchet et al.,
2002). The absence of Rrp6p was therefore expectedhelicase SEN1 (Rasmussen and Culbertson, 1998).
The association of Ssu72p with CPF raised the possi- to stabilize transcriptional readthrough products. Total
RNAs from ssu72-2, rrp6, and ssu72-2/rrp6 strainsbility that it might be required for 3 end formation activi-
ties. To test this we examined extracts from ssu72-2 obtained before and after shift to 37C were analyzed
by Northern blotting. In the double mutant strain, theand ProtA-SSU72 cells for in vitro cleavage and polyade-
nylation. Figure 3E shows that wild-type, ssu72-2, and normal CUP1 mRNA and an extended (approximately
1.7 kb) species accumulated (CUP1l; Figure 4Ai, lanesProtA-SSU72 extracts efficiently cleaved and polyade-
nylated a CYC1 pre-mRNA (lanes 2–4). A fip1-1 extract 8 and 9). Overexposure revealed low levels of CUP1l
also in ssu72-2 but not in wild-type or rrp6 strainsserved as control and was active in pre-mRNA cleavage
but lacked polyadenylation activity (lane 5) (Preker et (Figure 4Aiii, lanes 1–7). CUP1 expression is increased
when cells are shifted from 25C to 37C (Figure 4Ai,al., 1995). These results indicated that the ssu72-2 muta-
tion did not interfere with 3 end formation activities in lanes 1 and 2). Strikingly, CUP1 levels in ssu72-2/rrp6
cells grown at 25C were higher compared to levels invitro.
wild-type cells grown at 37C (Figure 4Aii). Because sin-
gle mutant strains did not display this phenotype, weDefective Regulation and Termination of CUP1
Transcription in ssu72-2/rrp6 Double Mutant Cells propose that the maintenance of regulated CUP1 levels
involves both Ssu72p and Rrp6p. Future experimentsMutants in 3 end factors can affect transcription termi-
nation in the absence of a defect in cleavage and polyad- have to address whether Ssu72p is involved in CUP1
regulation. Our results imply Rrp6p in monitoring “cor-enylation (Aranda and Proudfoot, 2001). To test ssu72-2
cells for defects in termination, we produced an ssu72-2 rect” CUP1 levels. Consistent with this hypothesis, re-
cent results suggest a more general role for Rrp6p instrain that lacked the nuclear exosome component
Molecular Cell
1144
Figure 4. Defective Regulation and Termination of CUP1 Transcription in ssu72-2/rrp6 Cells
(A) Northern analysis as described in Figure 3A of total RNA extracted from wild-type, ssu72-2, rrp6, and ssu72-2/rrp6 cells grown in YPD
medium at 25C (lanes 1, 3, 6, and 8) or following shift to 37C for the indicated times (lanes 2, 4, 5, 7, and 9). Positions of respective RNAs
are indicated for each panel. Also indicated are levels of CUP1 relative to 18S (ii) as determined by Phosphor Imager scanning (Storm,
Molecular Dynamics). (iii) shows an overexposure of a Northern blot probed for CUP1 mRNA to visualize low levels of CUP1l RNA in the
ssu72-2 single mutant (lane 5; indicated by an asterisk in [i] and [iii]).
(B) Schematic representation of the genomic CUP1 repeat unit. Indicated are the 0.6 CUP1 mRNA, the 1.7 kb CUP1-YHR54c dicistronic
transcript (CUP1l), and the positions of antisense oligonucleotides used in RNase H experiments.
(C) Total RNA from the ssu72-2/rrp6 cells grown at 25C was treated with oligonucleotides indicated in (B) and RNase H and analyzed by
Northern blotting as described in Figure 3A with the CUP1 probe (lanes 2–4). Oligonucleotide was omitted in lane 1. Migration of CUP1l and
CUP1 RNAs is indicated.
(D) Eight hundred nanograms poly(A) RNA (lane 2) and 10 g total RNA (lane 1) from ssu72-2/rrp6 cells grown at 25C were analyzed by
Northern blotting as described in Figure 3A. Migration of CUP1l, CUP1, and 18S RNAs is indicated.
the surveillance of nuclear mRNA levels (L. Milligan and summary, we found that low levels of extended tran-
scripts appeared for some tested mRNAs in the ssu72-D. Tollervey, personal communication). This could ex-
plain why the ssu72-2 single mutant strain did not show 2/rrp6 strain; this effect was clearly more pronounced
for CUP1. The presence of CUP1l in ssu72-2 cells sug-increased CUP1 levels.
Interestingly, transcription by RNAP II that lacks a gested that this mutation caused this effect. Moreover,
we predict that Rrp6p is involved in the turnover of theCTD produced a dicistronic CUP1-YHR54c RNA (Figure
4B) (McNeil et al., 1998). To test whether a similar tran- extended RNAs.
script accumulated in the ssu72-2/rrp6 strain, we tar-
geted RNase H degradation with oligonucleotides to Defective Transcription Elongation Contributes
to the ssu72-2 Growth Defectpositions downstream of the CUP1 polyadenylation site
and performed Northern analysis. CUP1l transcripts Transcription run-on analysis (TRO) monitors the pro-
duction of nascent transcripts and reflects the relativewere reduced in size dependent on the oligonucleotide
employed (Figure 4C), proving that they were 3-extended density of RNAP II molecules along a gene. ssu72-2 cells
were tested by TRO with a GAL1/10-controlled CYC1forms of CUP1 that resulted from transcriptional read-
through at the CUP1 terminator. Copurification of CUP1l gene (Figure 5A) (Birse et al., 1998) following growth in
synthetic galactose-based medium at 25C and 37C.with poly(A) RNA indicated that it was polyadenylated
(Figure 4D). To test whether stabilization of extended Correct termination at the CYC1 terminator results in
run-on signals over probes spanning P1–P3, but nottranscripts was a general feature of the ssu72-2/rrp6
strain, we examined several other mRNAs. For HSP82 P4–P6 regions (Birse et al., 1998). ssu72-2 cells grown
at 25C or 37C did not have a significantly increasedand SSA4 mRNAs, detectable smears of extended RNAs
were visible at 37C (Figures 4Aiv and 4Av, lane 9). In RNAP II density downstream of the CYC1 terminator
(Figure 5B); however, the P2 signal was somewhat in-contrast, no extended transcripts could be seen when
CYH2 or ACT1 mRNAs were tested (data not shown). In creased. The absence of Rrp6p could potentially ac-
SSU72 in Transcription Elongation and Termination
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Figure 5. TRO Analyses of ssu72-2 Cells
(A) Schematic representation of the CYC1
gene that was analyzed by TRO. M13 probes
(P1–P6) complementary to regions of the
CYC1 gene (indicated in nucleotides relative
to the transcription start site) and the poly(A)
site are indicated.
(B) Slot-hybridizations and quantification of
run-on transcripts obtained after TRO analy-
sis (Birse et al., 1998) of wild-type and
ssu72-2 cells grown in synthetic medium con-
taining 2% galactose at 25C or 37C for 2 hr.
P1–P6 represent probes complementary to
CYC1 transcripts as described in (A); empty
M13 and ACT probes served as controls. Val-
ues obtained by Phosphor Imager Scanning
(Storm) were corrected by subtraction of the
M13 background signal and normalized to the
value of P1 that was fixed at 100%. Values
shown represent the mean value of three sep-
arate assays.
(C) TRO time course analyses of wild-type,
ssu72-2, and pta1-1 cells that were grown in
synthetic medium containing 2% raffinose/
0.08% glucose at 25C and shifted to 37C
for the indicated times. CYC1 expression was
induced by addition of liquid galactose (2%
final concentration), and incubation was con-
tinued for 1 hr at the same temperature. TRO
and quantification of run-on transcripts was
as described in (B). Shown are the values
of single time course experiments. Increased
run-on transcripts over P2 compared to P1
in ssu72-2 cells induced at 37C were repro-
duced in three separate assays.
count for the readthrough observed in the ssu72-2/rrp6 the signal over P2 compared to P1 increased up to
5-fold in ssu72-2 cells when transcription was inducedstrain. However, TRO analyses of rrp6 and isogenic
wild-type strains did not reveal a termination defect following growth at 37C but not 25C. The concomitant
decrease of the relative RNAP II density before and(data not shown). We conclude that 3-extended CUP1
transcripts observed in ssu72-2 and ssu72-2/rrp6 cells behind the P2 region indicated that RNAP II molecules
get trapped at the pause site within P2. This suggesteddid not result from a general defect in RNAP II termi-
nation. a defect of ssu72-2 cells in elongation. To test whether
the pile up of RNAP II can be observed with other mu-The absence of clear TRO phenotypes might result
from the low penetrance of the ssu72-2 mutation that tants in CPF, we analyzed a pta1-1 mutant strain (O’Con-
nor and Peebles, 1992) under the same conditions. Atmight be enhanced when CYC1 expression is induced
at the nonpermissive temperature. Interestingly, TRO 25C the pta1-1 strain behaved like wild-type. TRO sig-
nals were clearly reduced when transcription was in-analyses of wild-type cells that were induced following
growth at 25C or 37C revealed an approximately 2-fold duced after shift to 37C, but quantification revealed
that the relative intensity of P2 signals compared to P1increase of run-on transcripts over P2 compared to P1
(Figure 5C). Since P2 still lies within the transcribed did not increase at 37C. These observations indicated
distinctly different defects of pta1-1 and ssu72-2 strainsCYC1 region, transcription elongation appeared limiting
under these conditions. Potentially, a pause site within in transcription. We did not further investigate pta1-1
here, but conclude that the pile up of RNAP II within thethe P2 region was involved in this observation. Strikingly,
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Figure 6. Influence of 6-AU on ssu72-2
Growth
Ten-fold serial dilutions of wild-type and
ssu72-2 strains grown in liquid YPD medium
(1% yeast extract, 2% bacto-peptone, 2%
glucose) at 25C were spotted on the same
medium (plus 2% agar) containing the indi-
cated amounts of 6-AU (upper panels). The
same strains transformed with pRS416
(URA3-CEN) were grown in synthetic medium
(SD-ura; 0.67% yeast nitrogen base, 2% glu-
cose, 1 complete drop out mix lacking ura-
cil) at 25C and spotted on the same medium
(plus 2% agar) containing the indicated
amounts of 6-AU (middle panels). The time
of growth was 3 days for all panels at the
respective temperatures (indicated on the
left). The bottom panel shows enlarged im-
ages of strains grown on SD-ura plus the indi-
cated amount of 6-AU at 30C to better visual-
ize differences in colony size.
CYC1 gene observed in ssu72-2 cells is not a general on YPD medium. At higher temperatures (36C), no sup-
pression was observed with the tested amounts of 6-AU.feature of mutants in CPF.
6-azauracil (6-AU) inhibits enzymes required for the At 33C, 1 g/ml 6-AU gave strong suppression on SD-
ura; higher concentrations resulted in strongly de-synthesis of UTP and GTP (Exinger and Lacroute, 1992).
The decrease of intracellular ribonucleotide levels is be- creased growth of both wild-type and mutant cells. Inter-
estingly, we observed that colonies of mutant cells werelieved to reduce RNAP II transcription and to cause
hypersensitive phenotypes of mutants that affect elon- clearly larger compared to wild-type at 30C in the pres-
ence of 25 g/ml 6-AU; with higher concentrations ofgation. Notably, several alleles of RPB2 that display
6-AU sensitivity also showed increased transcriptional 6-AU (50–75 g/ml), this effect was less pronounced.
Taken together, we observed that suppression of thearrest at pause sites in vitro (Powell and Reines, 1996).
Since the rpb2-100 allele was isolated as suppressor of ssu72-2 growth deficiency at nonpermissive tempera-
tures was strongly dependent on 6-AU concentrations.the ssu72-2 growth defect (Pappas and Hampsey, 2000),
we reasoned that 6-AU might duplicate this suppres- Conversely, the ssu72-2 mutation reduced 6-AU-medi-
ated growth inhibition on SD-ura medium at permissivesion. We tested this by growing wild-type and ssu72-2
cells on rich YPD medium or by growing the same strains temperature. This suggested that the ssu72-2 growth
defect could be rescued by reduction of intracellularcarrying a CEN-URA3 plasmid on synthetic medium
lacking uracil (SD-ura). Both strains grew without any GTP and UTP levels. These observations provided addi-
tional and independent evidence that ssu72-2 cells areapparent differences on YPD and SD-ura at 30C (Figure
6). The mutant displayed a ts phenotype on YPD and defective in elongation. We conclude that defective
elongation in ssu72-2 cells contributes to lethality andSD-ura at 33C. Growth inhibition was strongly sup-
pressed with increasing amounts of 6-AU (25–100g/ml) that the same deficiency opposes the effects of 6-AU.
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Discussion influence the properties of RNAP II. Mutants in Rpb2p
often display increased transcriptional arrest and sensi-
tivity to 6-AU (Powell and Reines, 1996). The growthThree lines of evidence support the idea that Ssu72p
defect of ssu72-2 cells was suppressed by a mutationhas a function early in transcription at gene promoters:
in Rpb2p (rpb2-100) that had a negative effect on tran-(i) the ssu72-1 allele enhanced a transcription start site
scription (Pappas and Hampsey, 2000), and 6-AU dupli-defect in a TFIIB mutant background (Sun and Hampsey,
cated this suppression. This indicated that a growth-1996); (ii) Ssu72p physically interacted with TFIIB (Wu
limiting defect in ssu72-2 cells was antagonized whenet al., 1999; this work); and (iii) chromatin-IP experiments
transcription was reduced. Conversely, the ssu72-2 mu-located subunits of CPF in the vicinity of promoter re-
tation reduced 6-AU toxicity. Since these phenotypesgions (Licatalosi et al., 2002). Since Ssu72p is stably
strongly depended on 6-AU concentration, we proposeassociated with CPF, these observations support the
that elongation rates were a critical factor. These obser-idea that Ssu72p functions in the recruitment of CPF to
vations indicated that elongation of RNAP II was in-TFIIB during preinitiation complex assembly. Recruit-
creased in ssu72-2 mutant cells, suggesting a negativement of CPSF to TFIID was reported to occur at meta-
influence of Ssu72p/CPF in the wild-type. Increasedzoan promoters (Dantonel et al., 1997). The strong evolu-
RNAP II elongation may result in stalling when othertionary conservation of eukaryotic Ssu72p proteins
cotranscriptional events, e.g., chromatin remodeling,(Pappas and Hampsey, 2000) may indicate that it con-
become rate limiting. Such effects may explain why atributes to this process in mammalian cells as well.
pile up of RNAP II occurred within the CYC1 gene inThree lines of evidence support a function of Ssu72p
ssu72-2 cells. Suppression of growth defects by 6-AUin transcription also following escape of RNAP II into
was also observed for cold-sensitive spt5 mutants (Hart-elongation: (i) TRO analyses revealed increased RNAP II
zog et al., 1998). Spt4p-Spt5p act cotranscriptionallypausing within the CYC1 gene in ssu72-2 cells following
and influence the ability of RNAP II to overcome nucleo-induction at nonpermissive temperature; (ii) 6-AU sup-
some barriers. 6-AU-mediated reduction of elongationpressed the ssu72-2 growth defect and ssu72-2 reduced
rates in spt5 mutants was proposed to compensate for6-AU toxicity; and (iii) the ssu72-2 mutation resulted
decreased Spt4p-Spt5p activity and thus reduced prob-in deficient termination at the CUP1 terminator. CPF
ability of RNAP II stalling. Therefore, the function ofassociates with elongating RNAP II in vivo (Licatalosi et
Spt4p-Spt5p provides one example which illustratesal., 2002), and we recently recapitulated the specific
that elongation rates of RNAP II have to be controlledinteraction of the CPF subunit Yhh1p/Cft1p with the
to ensure that chromatin structure will not limit transcrip-phosphorylated CTD in vitro (Dichtl et al., 2002). Ssu72p
tion. A second example is related to our finding thatwas found to bind to purified RNAP II in vitro (Pappas
ssu72-2 reduced the growth-limiting effects of 6-AU.and Hampsey, 2000), and we provide evidence that this
Suppression of 6-AU toxicity was observed in yeastinteraction is mediated by the Rpb2p subunit. Ssu72p
strains lacking the CHD1 gene that was suggested tomay directly influence RNAP II by contacting Rpb2p.
interfere with gene expression by altering chromatinAlternatively, binding of Ssu72p to Rpb2p might position
(Woodage et al., 1997). The control of RNAP II elongationCPF in close proximity to the polymerase to facilitate
transfer to the CTD or promote the association of CPF that we propose to involve Ssu72p/CPF might therefore
act to avoid collision at chromatin structures that in-with already elongating RNAP II. Our analyses sug-
gested that interactions of Rpb2p, TFIIB, Ydh1p, and crease the chance of pausing. Furthermore, differences
in the chromatin environment could account for thePta1p were impaired with mutant ssu72-2p. Reduced
interactions of Ssu72p or CPF, respectively, with RNAP gene-specific defects we observed in the ssu72-2
mutant.II may therefore account for the deficiencies in ssu72-2
mutant cells. At this point we cannot exclude that the How do Ssu72p/CPF influence RNAP II during termi-
nation? A defect in elongation would be expected tossu72-2 mutation indirectly affects other CPF-RNAP II
interactions, e.g., by reduced recruitment of CPF to pro- oppose defects in termination by decreasing the proba-
bility of transcription beyond the 3 end of a gene. Con-moters. Because of this limitation, we will refer to defects
in ssu72-2 cells as associated with Ssu72p/CPF for the sistent with this, we did not find a general termination
defect in ssu72-2 cells. The association of Ssu72p/CPFremainder of the Discussion section.
The analysis of factors involved in transcription elon- with the RNA substrate during poly(A) site recognition
in the wild-type may mirror reduced protein-protein in-gation in vivo is severely limited by the lack of suitable
assay systems. We found by TRO analysis of a GAL1/10- teractions that we think cause the defect during elonga-
tion in the ssu72-2 mutant. Defects in mutant cells duringcontrolled CYC1 gene that elongation appears limiting
within the initial hours of induction in wild-type cells. elongation may therefore be functionally relevant for
termination in the wild-type cell. Relief of the negativeThe reason for this observation is unclear but may result
from an initial restriction in the availability of factors effect of Ssu72p/CPF on RNAP II during elongation may
function to increase the probability of stalling duringrequired for elongation. Since the ssu72-2 mutation
clearly enhanced RNAP II pausing within the CYC1 gene termination. Such a mechanism may involve RNAP II
pause sites that were suggested to synergize with up-under these conditions, we propose that Ssu72p/CPF
are required for proper elongation. Consistent with the stream poly(A) signals in termination (Birse et al., 1997).
If this hypothesis is valid, functional elongation is pre-relatively late onset of lethality in ssu72-2 cells, the de-
fect in RNAP II elongation did apparently not affect all dicted to result in defective termination in the ssu72-2
mutant. Consistently, we observed that RNAP II mole-RNAP II molecules as judged by TRO analyses.
How do Ssu72p/CPF affect RNAP II during elonga- cules that escaped pausing were defective in termina-
tion since low levels of extended transcripts accumu-tion? We favor a model in which Ssu72p/CPF directly
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cleavage with 600 U of TEV protease in 1 ml TEV buffer (50 mMlated for some of the tested mRNAs in the ssu72-2/rrp6
Tris-Cl pH 8.0, 0.5 mM EDTA, 1 mM DTT, 30 mM KCl, 0.02% NP-strain. Unlike most genes, CUP1 can be transcribed by
40, and 10% glycerol) for 100 min at 16C, followed by five 1 mlRNAP II in the absence of the CTD; however, a dicis-
washes with TEV buffer. Elution fractions one to three were pooled
tronic CUP1-YHR54c mRNA is produced under these and applied to a SMART MiniQ column (100 l volume). The column
conditions (McNeil et al., 1998). Consequently, CTD- was developed with a linear KCl gradient (50–500 mM) and 50 l
fractions were collected. CPF peak fractions eluted at approximatelyassociated factors are dispensable for CUP1-YHR54c
310 mM KCl. CF IA was obtained following the procedure as de-transcription elongation, but not for termination at the
scribed for CPF, but with YWK200 extracts. During SMART MonoQCUP1 terminator. The molecular basis for the excep-
chromatography CF IA eluted at approximately 220 mM KCl.tional behavior of the CUP1 gene is unclear but might
reflect a chromatin environment that allows transcription Recombinant Proteins
in the absence of RNAP II-associated elongation and Production of GST-fusion proteins and in vitro translation was done
chromatin-remodeling factors. Appearance of the CUP1- as described (Dichtl et al., 2002). GST pull-down assays were per-
formed essentially as described by Ohnacker et al. (2000). GST-YHR54c transcript in ssu72-2 and ssu72-2/rrp6 cells
Nab4p and Pab1p were gifts from L. Minvielle-Sebastia and A.suggested that defective termination occurred when
Sachs, respectively. A polyclonal antiserum was raised against His6-elongation is functional. The observation that the CUP1-
Ssu72p (Eurogentech, Belgium).
YHR54c RNA was polyadenylated might indicate that
RNAP II molecules that had not been equipped with RNA Analyses
CPF at the CUP1 promoter might acquire the factor Northern analyses were done as described (Dichtl et al., 2002). PCR
once RNAP II has passed the CUP1 terminator. Consis- products covering the following sequences served as templates for
probes: PGK1 (nt 1–1251), CYH2 (nt 1–450), ADH1 (nt 1–1049), CUP1tent with this proposal, the association of 3 end factors
(nt 1–186), CYC1 (nt 1–629), ASC1 (nt 1–530), ACT1 (nt 1–677), HSP82with RNAP II also occurs during transcription (Licatalosi
(nt 1–750), and SSA4 (nt 1–700). Oligonucleotide probes were labeledet al., 2002). Interactions of CPF subunits other than
with -[32P]-ATP and T4 polynucleotide kinase: anti-18S (CAGACAA
Ssu72p (e.g., Yhh1p/Cft1p) with RNAP II could be in- ATCACTCCA), anti-5S (CTACTCGGTCAGGCTC), anti-U24 (TCAGA
volved in this recruitment. GATCTTGGTGATAAT), anti-U14 (TCACTCAGACATCCTAGG), and
In summary, we propose that Ssu72p/CPF acts to snR13-3 (GGTCAGATAAAAGTAAAAAAAGGTAGC). RNase H and
primer extension analyses are described in Supplemental Materialbalance elongation and termination by decreasing the
at http://www.molecule.org/cgi/content/full/10/5/1139/DC1. Tran-rate of elongation of RNAP II. Our experiments outline
scriptional run-on analysis was performed according to Birse et al.a molecular model for the antitermination function of 3
(1998).
end factors during transcription. Interestingly, splicing
factors were recently shown to have a stimulatory effect Identification of Polypeptides in CPF
on elongation (Fong and Zhou, 2001). Therefore, we MALDI-MS analysis and nano electrospray tandem mass spectro-
metric analysis of CPF fractions are described in detail in Supple-expect that additional functions of RNA processing fac-
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